The Experts below are selected from a list of 1140 Experts worldwide ranked by ideXlab platform
Amitabh Gulati - One of the best experts on this subject based on the ideXlab platform.
-
The Use of Lumbar Sympathetic Blockade at L4 for Management of Malignancy-Related Bladder Spasms
Pain Physician, 2011Co-Authors: Amitabh GulatiAbstract:Background: Cancer-related Bladder Spasms may be a rare but severe symptom of Bladder or metastatic cancer or its related treatments. Various treatments described in the literature include systemic medications, intravesical or epidural medications, or even sacral neurolectomies. Objective: We present 3 patients who have suffered from Bladder Spasm either from invasion of the Bladder wall by tumor (2 patients) or from intravesical chemotherapeutic treatment. Design: Case Report. Setting: Cancer pain management hospital. Methods: For each patient, we describe the use of lumbar sympathetic block to successfully treat the Bladder Spasms. Sympathetic blockade was performed at the left anterolateral border of lumbar vertebra L4. We used 10 mL of local anesthetic (0.25% bupivacaine) delivered in 2 mL aliquots, each given after negative aspiration for heme. Each procedure was performed with fluoroscopic guidance (both AP and lateral views) with the use of iodine contrast (Omnipaque-180) to confirm the location of the medication and its resulting spread. Results: All 3 patients had a reduction in the frequency and intensity of Spasms, with 2 out of 3 patients not having a recurrence of the Spasms for up to 2 months post procedure and follow up. Limitations: Case Report. Conclusion: Lumbar sympathetic blockade could be a useful treatment for recurrent Bladder Spasm in the oncologic population. Based on these findings, we feel that the branches of the sympathetic nerve set at L4 may be a good target for neurolytic procedures, such as radiofrequency ablation, for long term treatment of Bladder Spasms. Further research is necessary to determine the efficacy of this technique for the treatment of Bladder Spasms in the oncologic population. Key words: Bladder Spasm, cancer pain, splanchnic nerve, lumbar sympathetic block
-
The use of lumbar sympathetic blockade at L4 for management of malignancy-related Bladder Spasms.
Pain physician, 2011Co-Authors: Amitabh Gulati, Yury Khelemsky, Jeffrey Loh, Vinay Puttanniah, Vivek Malhotra, Kenneth CubertAbstract:Background Cancer-related Bladder Spasms may be a rare but severe symptom of Bladder or metastatic cancer or its related treatments. Various treatments described in the literature include systemic medications, intravesical or epidural medications, or even sacral neurolectomies. Objective We present 3 patients who have suffered from Bladder Spasm either from invasion of the Bladder wall by tumor (2 patients) or from intravesical chemotherapeutic treatment. Design Case Report. Setting Cancer pain management hospital. Methods For each patient, we describe the use of lumbar sympathetic block to successfully treat the Bladder Spasms. Sympathetic blockade was performed at the left anterolateral border of lumbar vertebra L4. We used 10 mL of local anesthetic (0.25% bupivacaine) delivered in 2 mL aliquots, each given after negative aspiration for heme. Each procedure was performed with fluoroscopic guidance (both AP and lateral views) with the use of iodine contrast (Omnipaque-180) to confirm the location of the medication and its resulting spread. Results All 3 patients had a reduction in the frequency and intensity of Spasms, with 2 out of 3 patients not having a recurrence of the Spasms for up to 2 months post procedure and follow up. Limitations Case Report. Conclusion Lumbar sympathetic blockade could be a useful treatment for recurrent Bladder Spasm in the oncologic population. Based on these findings, we feel that the branches of the sympathetic nerve set at L4 may be a good target for neurolytic procedures, such as radiofrequency ablation, for long term treatment of Bladder Spasms. Further research is necessary to determine the efficacy of this technique for the treatment of Bladder Spasms in the oncologic population.
Qu Hai-hong - One of the best experts on this subject based on the ideXlab platform.
-
Study on the effects of Bladder irrigation lotion's temperature on Bladder Spasm in patients after transurethral electrovaporization of the prostate
Journal of Nursing Administration, 2012Co-Authors: Qu Hai-hongAbstract:Objective To explore the effects of Bladder irrigation with different temperature lotions on Bladder Spasm in patients after transurethral electrovaporization of the prostate(TVP).Methods Fifty patients were involved to receive Bladder irrigation with 34~36 ℃ lotion,while another 50 patients received Bladder irrigation with 24 ℃ lotion.Results The incidence of Bladder Spasm and hospital stays in the experimental group were lower than the control group(P0.05).Conclusion Bladder irrigation with 34~36 ℃ lotion can prevent and reduce the incidence and severity of Bladder Spasm after TVP.
Yuqiang Liu - One of the best experts on this subject based on the ideXlab platform.
-
Transcutaneous electrical stimulation of somatic afferent nerves in the foot relieved symptoms related to postoperative Bladder Spasms.
BMC urology, 2017Co-Authors: Chanjuan Zhang, Zhiying Xiao, Xiulin Zhang, Liqiang Guo, Wendong Sun, Changfeng Tai, Zhaoqun Jiang, Yuqiang LiuAbstract:Bladder Spasm is a common side effect of urological surgery. Main treatment modalities include opioids or anticholinergic medication; however, Bladder Spasms still occur even after these interventions. Recent studies indicate that transcutaneous stimulation of the foot can result in 50% increase in Bladder capacity in healthy adults, and inhibit Bladder detrusor overactivity in spinal cord injured patients. In this study, we examined the effects of transcutaneous electrical stimulation of the foot on Bladder Spasms related symptoms. Sixty-six male patients who underwent prostate or Bladder surgeries due to benign prostatic hyperplasia or Bladder diseases were randomly divided into two groups: the control group (n = 36) and the treatment group (n = 30). The control group received the routine postoperative care. The treatment group received daily transcutaneous electrical stimulation of the foot during 3 days after surgery; each time lasted for 60 min. All patients were evaluated by the Visual Analogue Scale for pain sensation, frequency of Bladder Spasm episodes, and a total score of Bladder Spasms symptoms. In the control group, the patients with Bladder surgery had a higher Visual Analogue Scale score than patients with prostate surgery (P = 0.024). In both treatment and control groups, the Visual Analogue Scale score, Spasm frequency, and total score of Bladder Spasm symptoms decreased from day 1 to day 3 (P
-
Transcutaneous electrical stimulation of somatic afferent nerves in the foot relieved symptoms related to postoperative Bladder Spasms
BMC, 2017Co-Authors: Chanjuan Zhang, Zhiying Xiao, Xiulin Zhang, Liqiang Guo, Wendong Sun, Changfeng Tai, Zhaoqun Jiang, Yuqiang LiuAbstract:Abstract Background Bladder Spasm is a common side effect of urological surgery. Main treatment modalities include opioids or anticholinergic medication; however, Bladder Spasms still occur even after these interventions. Recent studies indicate that transcutaneous stimulation of the foot can result in 50% increase in Bladder capacity in healthy adults, and inhibit Bladder detrusor overactivity in spinal cord injured patients. In this study, we examined the effects of transcutaneous electrical stimulation of the foot on Bladder Spasms related symptoms. Methods Sixty-six male patients who underwent prostate or Bladder surgeries due to benign prostatic hyperplasia or Bladder diseases were randomly divided into two groups: the control group (n = 36) and the treatment group (n = 30). The control group received the routine postoperative care. The treatment group received daily transcutaneous electrical stimulation of the foot during 3 days after surgery; each time lasted for 60 min. All patients were evaluated by the Visual Analogue Scale for pain sensation, frequency of Bladder Spasm episodes, and a total score of Bladder Spasms symptoms. Results In the control group, the patients with Bladder surgery had a higher Visual Analogue Scale score than patients with prostate surgery (P = 0.024). In both treatment and control groups, the Visual Analogue Scale score, Spasm frequency, and total score of Bladder Spasm symptoms decreased from day 1 to day 3 (P
Kenneth Cubert - One of the best experts on this subject based on the ideXlab platform.
-
The use of lumbar sympathetic blockade at L4 for management of malignancy-related Bladder Spasms.
Pain physician, 2011Co-Authors: Amitabh Gulati, Yury Khelemsky, Jeffrey Loh, Vinay Puttanniah, Vivek Malhotra, Kenneth CubertAbstract:Background Cancer-related Bladder Spasms may be a rare but severe symptom of Bladder or metastatic cancer or its related treatments. Various treatments described in the literature include systemic medications, intravesical or epidural medications, or even sacral neurolectomies. Objective We present 3 patients who have suffered from Bladder Spasm either from invasion of the Bladder wall by tumor (2 patients) or from intravesical chemotherapeutic treatment. Design Case Report. Setting Cancer pain management hospital. Methods For each patient, we describe the use of lumbar sympathetic block to successfully treat the Bladder Spasms. Sympathetic blockade was performed at the left anterolateral border of lumbar vertebra L4. We used 10 mL of local anesthetic (0.25% bupivacaine) delivered in 2 mL aliquots, each given after negative aspiration for heme. Each procedure was performed with fluoroscopic guidance (both AP and lateral views) with the use of iodine contrast (Omnipaque-180) to confirm the location of the medication and its resulting spread. Results All 3 patients had a reduction in the frequency and intensity of Spasms, with 2 out of 3 patients not having a recurrence of the Spasms for up to 2 months post procedure and follow up. Limitations Case Report. Conclusion Lumbar sympathetic blockade could be a useful treatment for recurrent Bladder Spasm in the oncologic population. Based on these findings, we feel that the branches of the sympathetic nerve set at L4 may be a good target for neurolytic procedures, such as radiofrequency ablation, for long term treatment of Bladder Spasms. Further research is necessary to determine the efficacy of this technique for the treatment of Bladder Spasms in the oncologic population.
Yanling Peng - One of the best experts on this subject based on the ideXlab platform.
-
tolterodine tartrate in urethral stricture after the operation the application of the urine tube in patients with Bladder Spasm
2016Co-Authors: Yanling PengAbstract:Objective: To evaluate application of tolterodine tartrate in Bladder Spasm of patients with urethral stricture after urethral stenosis surgery. Methods: According to randomized double-blind placebo-controlled centricity research, 50 patients with urethral stricture were randomly divided into experimental group (25 cases) and control group (25 cases). Experimental group were treated with 2 mg tolterodine tartrate orally, 2 times/day 6 h after surgery, and the control group were given placebo vitamin C tablets. Results: The number of cases, the degree, the duration and frequency in the experimental group were less than those in the control group respectively, with significant difference (P<0.05). Conclusion: Tolterodine tartrate can effectively alleviate the symptoms of Bladder Spasm in patients with postoperative urethral stricture.
-
Tolterodine tartrate in urethral stricture after the operation, the application of the urine tube in patients with Bladder Spasm
2016Co-Authors: Yanling PengAbstract:Objective: To evaluate application of tolterodine tartrate in Bladder Spasm of patients with urethral stricture after urethral stenosis surgery. Methods: According to randomized double-blind placebo-controlled centricity research, 50 patients with urethral stricture were randomly divided into experimental group (25 cases) and control group (25 cases). Experimental group were treated with 2 mg tolterodine tartrate orally, 2 times/day 6 h after surgery, and the control group were given placebo vitamin C tablets. Results: The number of cases, the degree, the duration and frequency in the experimental group were less than those in the control group respectively, with significant difference (P